Actively Recruiting
Liposomal Bupivacaine Vs Bupivacaine with Dexmedetomidine in Erector Spinae Plane Blocks for Mastectomies
Led by United States Naval Medical Center, Portsmouth · Updated on 2024-11-19
200
Participants Needed
1
Research Sites
50 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Perform a comparison of effective pain relief duration between liposomal bupivacaine and dexmedetomidine when added to bupivacaine in a block for mastectomy for cancer surgery. The erector spinae plane block is a well-established block that is utilized for post operative pain control for procedures performed on the soft tissue of the chest and chest wall as well as intrathoracic procedures. The goal is comparison of the effective duration of both study groups to determine if there is a significant difference in time and amount of post operative opioids required which admitted to hospital.
CONDITIONS
Official Title
Liposomal Bupivacaine Vs Bupivacaine with Dexmedetomidine in Erector Spinae Plane Blocks for Mastectomies
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients requiring any variation of mastectomy with or without axillary lymph node dissection
- Patient agrees to a peripheral nerve block
- Patient agrees to be a study participant
- Acute Pain Service team believes a peripheral nerve block is appropriate after reviewing medical and surgical history
- Surgeon agrees with the peripheral nerve block plan by the Acute Pain Service team
You will not qualify if you...
- Patient declines a peripheral nerve block
- Patient declines to be a study participant
- Acute Pain Service team believes a peripheral nerve block is not clinically indicated
- Surgeon does not want a peripheral nerve block
- Patient has allergy to local anesthetic
- Patient has an active infection at the site of the peripheral nerve block
- Patient has pre-existing neural deficits along the block distribution
- Patient has coagulopathy
- Patient is taking antithrombotic drugs outside ASRA guidelines
- Patient weighs less than 50 kg due to risk of local anesthetic toxicity syndrome
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Naval Medical Center Portsmouth
Portsmouth, Virginia, United States, 23708
Actively Recruiting
Research Team
G
Grant A Miller, DO
CONTACT
T
Trevor O Elam, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here